In the TRAMP murine model of prostate cancer, tumor cells express functional CD1d molecules, but lead to aberrant iNKT-cell activation akin to anergy, likely through the inhibitory receptor Ly49 (70). This evidence concerns the gene CD1D and Familial prostate cancer.